Orciprenaline

Orciprenaline

Clinical data
Other names	Metaproterenol (USAN US)
AHFS/Drugs.com	Monograph
MedlinePlus	a682084
Pregnancy category	AU: A
Routes of administration	Inhalation (MDI) and tablets
ATC code	R03AB03 (WHO) R03CB03 (WHO) R03CB53 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) US: ℞-only
Pharmacokinetic data
Bioavailability	3% if inhaled, 40% if taken orally
Metabolism	Gastrointestinal and hepatic
Elimination half-life	6 hours
Identifiers
IUPAC name (RS)-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
JSmol)	Interactive image
Chirality	Racemic mixture
Solubility in water	9.7 mg/mL (20 °C)
SMILES Oc1cc(cc(O)c1)C(O)CNC(C)C
InChI InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3 Y Key:LMOINURANNBYCM-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Orciprenaline, also known as metaproterenol, is a

• tremor
• nervousness
• dizziness
• weakness
• headache
• nausea
• tachycardia

Rare side effects that could be life-threatening

• increased difficulty breathing
• rapid or increased heart rate
• irregular heartbeat
• chest pain or discomfort

Brand names

• Alupent
• Metaprel
• Orcibest

References